BLACK DIAMOND THERAPEUTICS, INC. (BDTX) Return on equity 2020–2025
BLACK DIAMOND THERAPEUTICS, INC. (BDTX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
19933.0%FY2025 · since FY2020: -21.9% → 19933.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 19933.0% | +103592.7 pp |
| FY2024 | -83659.7% | — |
| FY2020 | -21.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice